Caprock Group’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Caprock Group’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,139	Closed	-$21.7K	–	723
2023 Q3	$21.7K	Hold	4,139	–	–	﹤0.01%	656
2023 Q2	$29.2K	Hold	4,139	–	–	﹤0.01%	655
2023 Q1	$39.3K	Buy	4,139 +1,876	+83%	+$19.7K	﹤0.01%	634
2022 Q4	$13.8K	Hold	2,263	–	–	﹤0.01%	550
2022 Q3	$31K	Hold	2,263	–	–	﹤0.01%	563
2022 Q2	$91K	Hold	2,263	–	–	0.01%	540
2022 Q1	$238K	Buy	+2,263	New	+$166K	0.02%	507

Other funds holding NEXI

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Caprock Group's NEXI Position: Q4 2023 in Review

Caprock Group sold out of NexImmune, Inc. Common Stock (NEXI) in Q4 2023, closing a stake of 4,139 shares — an estimated $21.7K sold.

Caprock Group first reported a position in NEXI in Q1 2022 and held it in 7 quarters. The position peaked at $238K in Q1 2022. 11 funds tracked by Wall St. Rank hold NEXI as of Q4 2023.

Caprock Group reported no remaining NexImmune, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Caprock Group sold 4,139 NexImmune, Inc. Common Stock shares in Q4 2023, an estimated $21.7K.
Caprock Group first reported a position in NexImmune, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
Caprock Group's NexImmune, Inc. Common Stock position peaked at $238K in Q1 2022.
11 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2023.

Based on Caprock Group's 13F filing for Q4 2023, filed 18 Jan 2024.